The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

The Food and Drug Administration has approved the first GLP-1 pill for weight loss and maintenance. Drugmaker Novo Nordisk ...

Here's when you can get the FDA-approved, daily pill version of Novo Nordisk's wildly popular GLP-1 drug Wegovy.

The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment ...

The approval gives Novo Nordisk a leg up in the race to market a potent oral medication for shedding pounds as it looks to ...

Novo Nordisk's weight-loss pill, Wegovy, was approved by the FDA, giving the Danish drugmaker a leg up in the race to market ...

FDA approves Novo Nordisk's 25mg oral semaglutide (Wegovy) for weight loss, aiding 16.6% body weight reduction vs. 2.7% ...

The amount of time Wegovy remains in your system depends on the dosage and how long you have been taking the medication, with the drug potentially being detectable for up to 5 to 7 weeks after the ...

The FDA has approved the oral version of Novo Nordisk’s injectable weight loss drug Wegovy, making it the first GLP-1 pill to ...

The US Food and Drug Administration today approved a pill version of the blockbuster anti-obesity drug Wegovy. Made by Novo ...

Novo Nordisk A/S secures FDA nod for oral Wegovy, expanding obesity treatment options. Click for how oral GLP-1 therapies ...